National Health Investors (NHI) Expected to Announce Quarterly Earnings on Thursday

National Health Investors (NYSE:NHI) is projected to post its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect National Health Investors to post earnings of $1.23 per share and revenue of $95.1210 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Friday, February 27, 2026 at 10:00 AM ET.

National Health Investors Price Performance

Shares of NHI stock opened at $88.89 on Wednesday. The stock has a 50 day moving average price of $81.16 and a 200 day moving average price of $78.51. National Health Investors has a 52-week low of $66.41 and a 52-week high of $91.38. The company has a debt-to-equity ratio of 0.74, a quick ratio of 10.64 and a current ratio of 10.64. The firm has a market capitalization of $4.23 billion, a P/E ratio of 28.04, a P/E/G ratio of 3.08 and a beta of 0.66.

Institutional Trading of National Health Investors

A number of institutional investors have recently modified their holdings of NHI. Mercer Global Advisors Inc. ADV bought a new position in shares of National Health Investors during the 4th quarter worth approximately $352,000. EP Wealth Advisors LLC purchased a new position in National Health Investors in the fourth quarter worth $351,000. NewEdge Advisors LLC grew its holdings in National Health Investors by 111.6% in the fourth quarter. NewEdge Advisors LLC now owns 10,202 shares of the real estate investment trust’s stock worth $779,000 after purchasing an additional 5,380 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new position in shares of National Health Investors during the fourth quarter worth $33,000. Finally, Voloridge Investment Management LLC lifted its holdings in shares of National Health Investors by 1.6% during the 4th quarter. Voloridge Investment Management LLC now owns 76,629 shares of the real estate investment trust’s stock valued at $5,852,000 after purchasing an additional 1,238 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts have recently weighed in on NHI shares. Cantor Fitzgerald set a $85.00 target price on shares of National Health Investors in a research note on Monday, January 5th. Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a report on Monday, December 29th. Truist Financial upped their target price on shares of National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research note on Monday, December 15th. Wells Fargo & Company raised their target price on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 25th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a research note on Tuesday, January 20th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $85.57.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.